Change over period: —
NSE · LOTUSEYE
LOTUSEYE
-28.3% from the 52-week high · +3.1% above the low
Lotus Eye Hospital & Institute Ltd. engages in the provision of eye care and related services. The company is headquartered in Coimbatore, Tamil Nadu. The company went IPO on 2008-07-11. The firm operates primarily in the field of ophthalmology (Eye) and its related operations. The company resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The firm provides treatments through ReLEx SMILE, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The firm operates approximately seven centers at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin, and Mulanthurthy.
The short version. Promoter holding was 40.14% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
LOTUSEYE trades 28.3% below its 52-week high and 3.1% above its 52-week low.
2 · The business
Is it growing?
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2020 | |
|---|---|
| Revenue | 7 |
| Net profit | 0 |
| Net margin % | 1.1 |
| EPS (₹) | 0.04 |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.02 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 40.14 | 40.22 | 40.39 | 40.63 | 40.66 | 40.14 | 40.14 | 40.14 | 0.0 |
| FII | 0 | 0 | 0.01 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| DII | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | -0.02 |
| Public | 59.82 | 59.74 | 59.58 | 59.33 | 59.31 | 59.84 | 59.85 | 59.85 | +0.03 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for LOTUSEYE are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about LOTUSEYE
What is the LOTUSEYE share price?
LOTUSEYE (LOTUSEYE) last closed at ₹102.25, up 0.94% on the day. Its 52-week range is ₹98.22 to ₹141.38.
What is the market cap of LOTUSEYE?
LOTUSEYE has a market capitalisation of about ₹211 crore.
How are LOTUSEYE's latest results?
Promoter holding was 40.14% in Sep 2026, up 0.00 points over 8 quarters.
Who owns LOTUSEYE?
As of Sep 2026, shareholding was: Promoter 40.14%, DII 0.02%, Public 59.85%.
How many mutual funds hold LOTUSEYE?
0 mutual fund schemes held LOTUSEYE in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 18 Sep 2023 · Dividend - Rs. 0.5
- 08 Sep 2022 · Dividend - Rs. 0.5
- 08 Sep 2021 · Dividend - Rs. 0.5
- 14 Sep 2018 · Dividend - Rs. 0.5
- 02 Aug 2017 · Dividend - Rs. 0.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.